SACHDEVA, M.; DHINGRA, S.; PARLE, M. Dapagliflozin: a new adjunct in the treatment of Type 2 diabetes mellitus. International Journal of Basic & Clinical Pharmacology, [S. l.], v. 3, n. 4, p. 741–747, 2017. Disponível em: https://www.ijbcp.com/index.php/ijbcp/article/view/1067. Acesso em: 28 apr. 2024.